Gene · 4593
Papers3,141
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,141
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Myasthenia gravis: Mechanisms, clinical syndromes, and diagnosis. | Dis Mon | 2025 | 40579340 | PubTator, text mining | PubMed |
| MGBase: A Global, Observational Registry for Collaborative Research in Myasthenia Gravis. | Muscle Nerve | 2025 | 40468746 | PubTator, text mining | PubMed |
| Myasthenia Gravis Presenting With Vocal Cord Paralysis As the Initial Symptom Occurring One Week Following Herpes Zoster Vaccination: A Case Report and Review of the Literature. | Cureus | 2025 | 40462824 | PubTator, text mining | PubMed |
| The Role of Complement in the Pathogenesis and Treatment of Myasthenia Gravis. | Cells | 2025 | 40422242 | PubTator, text mining | PubMed |
| The Fusion Protein MuSK-Fc Functions as a Decoy to Block the Binding of Anti-MuSK Antibodies to MuSK. | Scand J Immunol | 2025 | 40411208 | PubTator, text mining | PubMed |
| A multi-level gene-diet interaction analysis of fish oil and 14 polyunsaturated fatty acid traits identifies the FADS and GPR12 loci. | HGG Adv | 2025 | 40405463 | PubTator, text mining | PubMed |
| Myasthenia gravis with double-seropositive acetylcholine receptor and low-density lipoprotein receptor-related protein 4 antibodies combined with muscle atrophy: a case report and literature review. | Front Immunol | 2025 | 40356916 | PubTator, text mining | PubMed |
| Agrin/Dok-7-induced JPH2 phosphorylation in muscle cells is involved in AChR clustering. | FEBS Lett | 2025 | 40290048 | PubTator, text mining | PubMed |
| Rozanolixizumab for Myasthenia Gravis: a breakthrough treatment and future prospects. | Immunotherapy | 2025 | 40277145 | PubTator, text mining | PubMed |
| [Treatment and clinical course of autoimmune myasthenia in Burkina Faso]. | Med Trop Sante Int | 2025 | 40248578 | PubTator, text mining | PubMed |
| SRSF6 and SRSF1 coordinately enhance the inclusion of human MUSK exon 10 to generate a Wnt-sensitive MuSK isoform. | NAR Mol Med | 2025 | 40161265 | PubTator, text mining | PubMed |
| Pyridostigmine-induced complete atrioventricular block in a patient with Musk antibody-negative myasthenia gravis a case report : Pyridostigmine-ind advanced AV block in MG patient with MuSK-neg. | BMC Cardiovasc Disord | 2025 | 40148780 | PubTator, text mining | PubMed |
| Efgartigimod for induction and maintenance therapy in muscle-specific kinase myasthenia gravis. | Ther Adv Neurol Disord | 2025 | 40144041 | PubTator, text mining | PubMed |
| Testing for Acetylcholine Receptor and Muscle-Specific Tyrosine Kinase Antibodies by Fixed Cell-Based Assay in Clinical Practice: Positive Predictive Value for Myasthenia Gravis. | Eur J Neurol | 2025 | 40130472 | PubTator, text mining | PubMed |
| Efgartigimod improves non-AChR generalized Myasthenia Gravis: a real world experience. | Neurol Sci | 2025 | 40128464 | PubTator, text mining | PubMed |
| Clinical Spectrum and Therapeutic Outcome of Myasthenia Gravis in a Tertiary Care Hospital: A Retrospective Study. | J Assoc Physicians India | 2025 | 40087931 | PubTator, text mining | PubMed |
| Prevalence and course of muscle-specific receptor tyrosine kinase (MuSK) antibodies in myasthenia gravis - A retrospective study. | J Neurol Sci | 2025 | 40086234 | PubTator, text mining | PubMed |
| Development and Application of a Cell-Based Assay for Detecting Anti-Agrin Antibodies Associated With Myasthenia Gravis. | J Clin Neurol | 2025 | 40065451 | PubTator, text mining | PubMed |
| A Case of Myasthenia Gravis: A Paraneoplastic Syndrome or an Immune-Related Disorder? | Cureus | 2025 | 40062097 | PubTator, text mining | PubMed |
| Double-seropositive Myasthenia Gravis Following COVID-19. | Intern Med | 2025 | 40058857 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4593/papers?page=9